PLA2G7, caloric restriction and cardiovascular aging

References

[1] Trends G.Public health and aging: trends in aging - United States and worldwide.JAMA2003;289:1371-3

[2] Lakatta EG.Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons.Heart Fail Rev2002;7:29-49

[3] Spadaro O,Shchukina I.Caloric restriction in humans reveals immunometabolic regulators of health span.Science2022;375:671-7

[4] Tellis CC.The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.Biochim Biophys Acta2009;1791:327-38

[5] Jiang D,Wang L.Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.PLoS One2013;8:e59752 PMCID:PMC3610900

[6] Speakman JR.Caloric restriction.Mol Aspects Med2011;32:159-221

[7] de Almeida AJPO,de Medeiros IA.Aging: molecular pathways and implications on the cardiovascular system.Oxid Med Cell Longev2017;2017:7941563 PMCID:PMC5569936

[8] Martel J,Wu CY.Recent advances in the field of caloric restriction mimetics and anti-aging molecules.Ageing Res Rev2021;66:101240

[9] Kristan DM.Calorie restriction and susceptibility to intact pathogens.Age (Dordr)2008;30:147-56 PMCID:PMC2527633

[10] Goldberg EL,Renkema KR.Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms.Aging Cell2015;14:130-8 PMCID:PMC4326902

[11] Kraus WE,Huffman KM.2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.Lancet Diabetes Endocrinol2019;7:673-83 PMCID:PMC6707879

[12] Garg SK,Shi H.Changes in adipose tissue macrophages and T cells during aging.Crit Rev Immunol2014;34:1-14 PMCID:PMC3942798

[13] Ferguson JF,Mehta NN.Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.J Am Coll Cardiol2012;59:764-72 PMCID:PMC3285416

[14] Tjoelker LW,Eberhardt C.Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.Nature1995;374:549-53

[15] White HD,Stewart R.STABILITY InvestigatorsDarapladib for preventing ischemic events in stable coronary heart disease.N Engl J Med2014;370:1702-11

[16] Lv SL,Gan WQ.Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.Acta Pharmacol Sin2021;42:2016-32 PMCID:PMC8632984

[17] Sokolova M,Hansen SH.NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet.Sci Rep2020;10:21006 PMCID:PMC7712828

[18] Ma Y,Lindsey ML.Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction.Transl Res2018;191:15-28 PMCID:PMC5846093

[19] Siddiqui MK,St Jean P.Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events.Diabetologia2022;65:101-12 PMCID:PMC8660745